The arrival of a new player in the IPO market is going on amidst constant lethargy in the stock market. If you also want to earn through IPO, then a new, Dr. Agrawals Health Care IPO is going to open for you on January 29. The company has shared the price band of this IPO at Rs 382-402 per. According to PTI news, Temacek Holdings and TPG -backed eye service provider Dr. Agrawals Health Care gave this information on Friday.
3,027.26 crore is the size of the issue
According to the news, the company said that it will be open for subscription from 29 January to 31 January of more than Rs 3,027 crore. The company announced that the bid for anchor investors would open for a day on January 28. This IPO is a combination of new issues up to Rs 300 crore and a selling offering of 6.78 crore equity shares (OFS) worth 6.78 crore equity shares worth Rs 2,727.26 crore at the upper end of the price band by promoters and other sales shareholders. Thus the total issue size is Rs 3,027.26 crore.
How much is the reserve for whom
This offer also includes membership for eligible employees. Arvon Investments PTE.LTD, Clemore Investments (Mauritius) PTE among those selling shares in O.S.S.
Ltd, and hyperrian investments pte.ltd. Are included. The company will use the amount of Rs 195 crore received from the new issue to pay the loan and in addition, one part will be used for general corporate purposes and unknown inorganic acquisitions. Half of output size is reserved for qualified institutional buyers, 35 percent for non-institutional investors and the remaining 15 percent for retail investors.
Know the company
Dr. Agrawals Health Care offers a wide range of services, including sales of medicines related to cataract, refractory and other surgery, consultation, diagnosis, non-surgical treatment and optical products, contact lenses, accessories and eye care related medicines. As of September 2024, its network included 193 features, most of which were concentrated in South India, especially Chennai, Hyderabad and Bengaluru, followed by Western India.
On the financial front, Dr. Aggarwal’s healthcare operations from the revenue financial year 2024 1,332. 15 crores was Rs 15 and the profit after tax was Rs 95. 05 crores. Kotak Mahindra Capital Company, Morgan Stanley India Company, Jeffers India and Motilal Oswal Investment Advisors are the book-hanging lead managers of this issue.
How much is Gmp
Dr. Agrawals Health Care has already started stirring the non-list market. According to Fortune India, the Gray Market Premium (GMP) of 164 is running on its shares. It is still very early to determine the trend as GMP can change in future based on market conditions.
Latest business news